UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: B | C | D | E | G | H | I | K | L | M | O | P | R | S | T | W
Number of items: 95.

B

Bagary, M.S. and Symms, M.R. and Barker, G.J. and Mutsatsa, S.H. and Joyce, E.M. and Ron, M.A. (2003) Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging. Archives of General Psychiatry , 60 (8) pp. 779-788. 10.1001/archpsyc.60.8.779.

Behrens, TEJ and Johansen-Berg, H and Woolrich, MW and Smith, SM and Wheeler-Kingshott, CAM and Boulby, PA and Barker, GJ and Sillery, EL and Sheehan, K and Ciccarelli, O and Thompson, AJ and Brady, JM and Matthews, PM (2003) Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. NAT NEUROSCI , 6 (7) 750 - 757. 10.1038/nn1075.

Bell, JB and Davies, RA and Thompson, EJ (2003) Herpes simplex encephalitis. A study of seven patients and their immunological response prior to routine acyclovir treatment. J INFECTION , 47 (2) 161 - 163. 10.1016/S0163-4453(03)00011-2.

C

Chard, DT and Brex, PA and Ciccarelli, O and Griffin, CM and Parker, GJM and Dalton, C and Altmann, DR and Thompson, AJ and Miller, DH (2003) The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study. J NEUROL NEUROSUR PS , 74 (11) 1551 - 1554.

Chard, DT and Griffin, CM and Rashid, W and Davies, GR and Altmann, DR and Kapoor, R and Barker, GJ and Thompson, AJ and Miller, DH (2003) Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1456 - 1456). B M J PUBLISHING GROUP

Chilcott, J and McCabe, C and Tappenden, P and O'Hagan, A and Cooper, NJ and Abrams, K and Claxton, K and Miller, DH (2003) Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis. BMJ (Clinical Research Ed.) , 326 (7388) 522 - 522.

Ciccarelli, O and Parker, GJM and Toosy, AT and Wheeler-Kingshott, CAM and Barker, GJ and Boulby, PA and Miller, DH and Thompson, AJ (2003) From diffusion tractography to quantitative white matter tract measures: a reproducibility study. NEUROIMAGE , 18 (2) 348 - 359. 10.1016/S1053-8119(02)00042-3.

Ciccarelli, O and Toosy, AT and Parker, GJM and Wheeler-Kingshott, CAM and Barker, GJ and Miller, DH and Thompson, AJ (2003) Diffusion tractography based group mapping of major white-matter pathways in the human brain. NEUROIMAGE , 19 (4) 1545 - 1555. 10.1016/S1053-8119(03)00190-3.

Ciccarelli, O and Werring, DJ and Barker, GJ and Griffin, CM and Wheeler-Kingshott, CAM and Miller, DH and Thompson, AJ (2003) A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging - Evidence of Wallerian degeneration. J NEUROL , 250 (3) 287 - 292. 10.1007/s00415-003-0992-5.

Ciccarelli, O. and Toosy, A.T. and Parker, J.M. and Wheeler-Kingshott, A.M. and Barker, G.J. and Miller, D.H. and Thompson, A.J. (2003) Diffusion tractography based group mapping of major white-matter pathways in the human brain. NeuroImage , 19 (4) pp. 1545-1555. 10.1016/S1053-8119(03)00190-3.

Cox, AL and Le Page, E and Coles, AJ and Miller, D and Hale, G and Waldman, H and Compston, DAS (2003) Campath-1H in the treatment of patients with worsening multiple sclerosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 407 - 407). BRITISH MED JOURNAL PUBL GROUP

Craner, MJ and Lo, AC and Black, JA and Baker, D and Newcombe, J and Cuzner, ML and Waxman, SG (2003) Annexin II/piII is up-regulated in Purkinje cells in EAE and MS. NEUROREPORT , 14 (4) 555 - 558. 10.1097/01.wnr.0000061018.47393.38.

D

Dalton, C and Barker, G and MacManus, D and Miszkiel, K and Bates, D and Blumhardt, L and Hawkins, C and Palace, J and Sharief, M and Swingler, R and Young, C and Miller, D and Int Natalizumab MS Trial Grp, (2003) The effectiveness of Natalizumab on MRI outcome measures in patients with relapsing multiple sclerosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 399 - 399). BRITISH MED JOURNAL PUBL GROUP

Dalton, CM and Brex, PA and Miszkiel, KA and Fernando, K and MacManus, DG and Plant, GT and Thompson, AJ and Miller, DH (2003) New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. ANN NEUROL , 53 (5) 673 - 676. 10.1002/ana.10580.

Dalton, CM and Brex, PA and Miszkiel, KA and Fernando, K and MacManus, DG and Plant, GT and Thompson, AJ and Miller, DH (2003) Spinal cord MRI in clinically isolated optic neuritis. J NEUROL NEUROSUR PS , 74 (11) 1577 - 1580.

Davies, G and Keir, G and Thompson, EJ and Giovannoni, G (2003) The clinical significance of an intrathecal monoclonal immunoglobulin band - A follow-up study. NEUROLOGY , 60 (7) 1163 - 1166.

Davies, GR and Hadjiprocopis, A and Rashid, W and Griffin, C and Chard, D and Barker, G and Tofts, P and Kapoor, R and Thompson, AJ and Miller, DH (2003) Evidence for progressive normal appearing grey and white matter MTR abnormality in early relapsing-remitting multiple sclerosis: A 2 year follow up study. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1450 - 1450). B M J PUBLISHING GROUP

Davies, GR and Ramani, A and Dalton, CM and Tozer, DJ and Wheeler-Kingshott, CAM and Barker, GJ and Thompson, AJ and Miller, DH and Tofts, PS (2003) Preliminary magnetic resonance study of the macromolecular proton fraction in white matter: a potential marker of myelin? MULT SCLER , 9 (3) 246 - 249. 10.1191/1352458503ms911oa.

De Vita, E and Thomas, DL and Roberts, S and Parkes, HG and Turner, R and Kinchesh, P and Shmueli, K and Yousry, TA and Ordidge, RJ (2003) High resolution MRI of the brain at 4.7 Tesla using fast spin echo imaging. BRIT J RADIOL , 76 (909) 631 - 637.

De Vita, E. and Thomas, D.L. and Roberts, S. and Parkes, H.G. and Turner, R. and Kinchesh, P. and Shmueli, K. and Yousry, T.A. and Ordidge, R.J. (2003) High resolution MRI of the brain at 4.7 Tesla using fast spin echo imaging. British Journal of Radiology , 76 (909) pp. 631-637. 10.1259/bjr/69317841.
An open access version is available from UCL Discovery
file

Dehmeshki, J and Chard, DT and Leary, SM and Watt, HC and Silver, NC and Tofts, PS and Thompson, AJ and Miller, DH (2003) The normal appearing grey matter in primary progressive multiple sclerosis - A magnetisation transfer imaging study. J NEUROL , 250 (1) 67 - 74. 10.1007/s00415-003-0955-x.

Diemel, LT and Jackson, SJ and Cuzner, ML (2003) Role for TGF-beta 1, FGF-2 and PDGF-AA in a myelination of CNS aggregate cultures enriched with macrophages. J NEUROSCI RES , 74 (6) 858 - 867. 10.1002/jnr.10837.

Dilley, A and Gregson, NA and Hadden, RD and Smith, KJ (2003) Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barré syndrome. Journal of Neuroimmunology , 139 (1) 133 - 140. 10.1016/S0165-5728(03)00156-5.

Dubois, B.D. and Keenan, E. and Porter, B.E, and Kapoor, R. and Rudge, P. and Thompson, A.J. and Miller, D.H. and Giovannoni, G. (2003) Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre. Journal of Neurology Neurosurgery & Psychiatry , 74 (7) pp. 946-949. 10.1136/jnnp.74.7.946.
An open access version is available from UCL Discovery
file

Dubois, BD and Keenan, E and Porter, BE and Kapoor, R and Rudge, P and Thompson, AJ and Miller, DH and Giovannoni, G (2003) Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre. J NEUROL NEUROSUR PS , 74 (7) 946 - 949.

E

Eikelenboom, MJ and Petzold, A and Lazeron, RHC and Silber, E and Sharief, M and Thompson, EJ and Barkhof, F and Giovannoni, G and Polman, CH and Uitdehaag, BMJ (2003) Multiple sclerosis - Neurofilament light chain antibodies are correlated to cerebral atrophy. NEUROLOGY , 60 (2) 219 - 223.

G

Giovannoni, G and Dubois, BD and Keenan, E and Porter, BE and Kapoor, R and Rudge, P and Thompson, AJ and Miller, DH (2003) Beta-interferon in multiple sclerosis: An assessment of the ABN stopping criteria in clinical practice. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1177 - 1178). BRITISH MED JOURNAL PUBL GROUP

Guye, M and Parker, GJM and Symms, M and Boulby, P and Wheeler-Kingshott, CAM and Salek-Haddadi, A and Barker, GJ and Duncan, JS (2003) Combined functional MRI and tractography to demonstrate the connectivity of the human primary motor cortex in vivo. NEUROIMAGE , 19 (4) 1349 - 1360. 10.1016/S1053-8119(03)00165-4.

Gveric, D and Herrera, B and Petzold, A and Lawrence, DA and Cuzner, ML (2003) Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors. BRAIN , 126 1590 - 1598. 10.1093/brain/awg167.

H

Hickman, SJ and Coulon, O and Parker, GJM and Barker, GJ and Stevenson, VL and Chard, DT and Arridge, SR and Thompson, AJ and Miller, DH (2003) Application of a B-spline active surface technique to the measurement of cervical cord volume in multiple sclerosis from three-dimensional MR images. JOURNAL OF MAGNETIC RESONANCE IMAGING , 18 (3) 368 - 371. 10.1002/jmri.10354.

Hickman, SJ and Kapoor, R and Jones, SJ and Altmann, D and Plant, GT and Miller, DH (2003) Corticosteroids do not prevent optic nerve atrophy following optic neuritis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 400 - 400). BRITISH MED JOURNAL PUBL GROUP

Hickman, SJ and Kapoor, R and Jones, SJ and Altmann, DR and Plant, GT and Miller, DH (2003) Corticosteroids do not prevent optic nerve atrophy following optic neuritis. J NEUROL NEUROSUR PS , 74 (8) 1139 - 1141.

Holley, JE and Gveric, D and Newcombe, J and Cuzner, ML and Gutowski, NJ (2003) Astrocyte characterization in the multiple sclerosis glial scar. NEUROPATH APPL NEURO , 29 (5) 434 - 444.

Horsfield, MA and Barker, GJ and Barkhof, F and Miller, DH and Thompson, AJ and Filippi, M (2003) Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. J MAGN RESON IMAGING , 17 (4) 389 - 397. 10.1002/jmri.10266.

Hughes, LE and Smith, PA and Bonell, S and Natt, RS and Wilson, C and Rashid, T and Amor, S and Thompson, EJ and Croker, J and Ebringer, A (2003) Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. Journal of Neuroimmunology , 144 (1-2) 105 - 115.

I

Ingle, GT and Stevenson, VL and Leary, SM and Miller, DH and Thompson, AJ (2003) A 5 year longitudinal MRI study of primary progressive multiple sclerosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1451 - 1451). B M J PUBLISHING GROUP

Ingle, GT and Stevenson, VL and Miller, DH and Thompson, AJ (2003) Primary progressive multiple sclerosis: a 5-year clinical and MR study. BRAIN , 126 2528 - 2536. 10.1093/brain/awg261.

Inglese, M and van Waesberghe, JHTM and Rovaris, M and Beckmann, K and Barkhof, F and Hahn, D and Kappos, L and Miller, DH and Polman, C and Pozzilli, C and Thompson, AJ and Yousry, TA and Wagner, K and Comi, G and Filippi, M (2003) The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS. NEUROLOGY , 60 (5) 853 - 860.

K

Kapoor, R and Davies, M and Blaker, PA and Hall, SM and Smith, KJ (2003) Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. ANN NEUROL , 53 (2) 174 - 180. 10.1002/ana.10443.

Kapoor, R. and Davies, M. and Blaker, P.A. and Hall, S.M. and Smith, K.J. (2003) Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Annals of Neurology , 53 (2) pp. 174-180. 10.1002/ana.10443.

Kay, A and Petzold, A and Kerr, M and Keir, G and Thompson, E and Nicoll, J (2003) Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage - Correlation with injury severity and clinical outcome. STROKE , 34 (3) 637 - 642. 10.1161/01.STR.0000057579.25430.16.

Kay, A and Petzold, A and Kerr, M and Keir, G and Thompson, E and Nicoll, J (2003) Temporal alterations in cerebrospinal fluid amyloid beta-p0rotein and apolipoprotein E after subarachnoid hemorrhage. STROKE , 34 (12) E240 - E243. 10.1161/01.STR.0000100157.88508.2F.

Kay, AD and Petzold, A and Kerr, M and Keir, G and Thompson, E and Nicoll, JAR (2003) Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury. J NEUROTRAUM , 20 (10) 943 - 952.

Kay, AD and Petzold, A and Kerr, M and Keir, G and Thompson, EJ and Nicoll, JAR (2003) Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury. J NEUROTRAUM , 20 (3) 243 - 250.

Kinchesh, P and Parkes, HJ and Ordidge, RJ (2003) Voxel selection at high field using frequency offset corrected inversion (FOCI) pulses. In: Proceedings of the International Society of Magnetic Resonance in Medicine. (pp. 1131 - 1131).

L

Lam, AJ and Pocock, JM and Heales, SJR (2003) Tetrahydrobiopterin deficiency and mitochondrial dysfunction in astrocytes: implication for neurodegeneration. In: JOURNAL OF NEUROCHEMISTRY. (pp. 131 - 131). BLACKWELL PUBLISHING LTD

Leary, SM and Miller, DH and Stevenson, VL and Brex, PA and Chard, DT and Thompson, AJ (2003) Interferon beta-1a in primary progressive MS - An exploratory, randomized, controlled trial. NEUROLOGY , 60 (1) 44 - 51.

Lycklama, G and Thompson, A and Filippi, M and Miller, D and Polman, C and Fazekas, F and Barkhof, F (2003) Spinal-cord MRI in multiple sclerosis. The Lancet Neurology , 2 (9) 555 - 562.

M

Miller, DH (2003) Commentary: Evaluating disease modifying treatments in multiple sclerosis. BRIT MED J , 326 (7388) 525 - 525.

Miller, DH (2003) Magnetic resonance imaging monitoring in clinical trials. In: Multiple sclerosis 2. (125 - 137). Butterworth Heinemann

Miller, DH (2003) Magnetic resonance imaging in multiple sclerosis: an overview. In: Cohen, JA and Rudick, RA and McFarland, H, (eds.) Multiple sclerosis therapeutics. (81 - 95). Martin Dunitz: London.

Miller, DH and Int Natalizumab MS trial grp, (2003) Natalizumab (anti-VLA4 antibody) in multiple sclerosis. In: JOURNAL OF NEUROCHEMISTRY. (pp. 96 - 96). BLACKWELL PUBLISHING LTD

Miller, DH and Khan, OA and Sheremata, WA and Blumhardt, LD and Rice, GPA and Libonati, MA and Willmer-Hulme, AJ and Dalton, CM and Miszkiel, KA and O'Connor, PW and Int Natalizumab Multiple Sclerosis, (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. NEW ENGL J MED , 348 (1) 15 - 23.
An open access version is available from UCL Discovery
file

Miller, DH and O'Connor, PW (2003) Natalizumab for relapsing multiple sclerosis - Reply. NEW ENGL J MED , 348 (16) 1598 - 1599.

Miller, DH and Thompson, AJ and Filippi, M (2003) Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. JOURNAL OF NEUROLOGY , 250 (12) 1407 - 1419. 10.1007/s00415-003-0243-9.

Mottershead, J.P. and Schmierer, K. and Clemence, M. and Thornton, J.S. and Scaravilli, F. and Barker, G.J. and Tofts, P.S. and Newcombe, J. and Cuzner, M.L. and Ordidge, R.J. and McDonald, W.I. and Miller, D.H. (2003) High field MRI correlates of myelin content and axonal density in multiple sclerosis. Journal of Neurology , 250 (11) pp. 1293-1301. 10.1007/s00415-003-0192-3.

Mottershead, JP and Schmierer, K and Clemence, M and Thornton, JS and Scaravilli, F and Barker, GJ and Tofts, PS and Newcombe, J and Cuzner, ML and Ordidge, RJ and McDonald, WI and Miller, DH (2003) High field MRI correlates of myelin content and axonal density in multiple sclerosis - A post-mortem study of the spinal cord. J NEUROL , 250 (11) 1293 - 1301. 10.1007/s00415-003-0192-3.

O

Ordidge, RJ and De Vita, E and Roberts, S and Parkes, HJ and Turner, R and Kinchesh, P and Shmueli, K and Thomas, DL (2003) High resolution imaging of the human brain at 4.7 Tesla using fast spin echoes. In: Proceedings of the International Society of Magnetic Resonance in Medicine. (pp. 794 - 794).

P

Page, RA and Bainbridge, A and West, DA and Thornton, J and Parkes, HJ and Cady, E and Bates, GP and Woodman, B and Ordidge, RJ and Davie, CA (2003) Dietary creatine supplementation in a mouse model of Huntington's disease. In: Proceedings International Society for Magnetic Resonance in Medicine 11th Annual Meeting. (pp. 194 - 194).

Page, RA and Bainbridge, A and West, DA and Thornton, J and Parkes, HJ and Cady, E and Bates, GP and Woodman, B and Ordidge, RJ and Davie, CA (2003) Dietary Creatine Supplementation in a Mouse Model of Huntington's Disease. In: (Proceedings) ISMRM Eleventh Meeting and Exhibition. International Society for Magnetic Resonance in Medicine

Parker, GJC and D, T (2003) Measurement of volumes and atrophy in the central nervous system. In: Tofts, P, (ed.) Quantitative magnetic resonance of the brain: measuring changes caused by disease. John Wiley & Sons: Chichester.

Parker, GJM and Haroon, HA and Wheeler-Kingshott, CAM (2003) A framework for a streamline-based probabilistic index of connectivity (PICo) using a structural interpretation of MRI diffusion measurements. JOURNAL OF MAGNETIC RESONANCE IMAGING , 18 (2) 242 - 254. 10.1002/jmri.10350.

Petzold, A and Baker, D and Pryce, G and Keir, G and Thompson, EJ and Giovannoni, G (2003) Quantification of neurodegeneration by measurement of brain-specific proteins. J NEUROIMMUNOL , 138 (1-2) 45 - 48. 10.1016/S0165-5728(03)00092-4.

Petzold, A and Jenkins, R and Watt, HC and Green, AJE and Thompson, EJ and Keir, G and Fox, NC and Rossor, MN (2003) Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease. NEUROSCI LETT , 336 (3) 167 - 170. 10.1016/S0304-3940(02)01257-0.

Petzold, A and Keir, G and Green, AJE and Giovannoni, G and Thompson, EJ (2003) A specific ELISA for measuring neurofilament heavy chain phosphoforms. J IMMUNOL METHODS , 278 (1-2) 179 - 190. 10.1016/S0022-1759(03)00189-3.

Petzold, A and Keir, G and Lim, D and Smith, M and Thompson, EJ (2003) Cerebrospinal fluid (CSF) and serum S100B: release and wash-out pattern. BRAIN RESEARCH BULLETIN , 61 (3) 281 - 285. 10.1016/S0361-9230(03)00091-1.

Petzold, A. (2003) Brain–specific proteins in Multiple Sclerosis. Doctoral thesis, University of London.
An open access version is available from UCL Discovery
file

Petzold, A. and Baker, D. and Pryce, G. and Keir, G. and Thompson, E.J. and Giovannoni, G. (2003) Quantification of neurodegeneration by measurement of brain-specific proteins. Journal of Neuroimmunology , 138 (1-2) pp. 45-48. 10.1016/S0165-5728(03)00092-4.
An open access version is available from UCL Discovery
file

Pocock, J (2003) Expression and function of microglial metabotropic glutamate receptors: implications for microglial reactivity and neurotoxicity. In: (Proceedings) VI European Meeting on Glial Cell function in health and disease.. (pp. S7.3 - ?). Glia

Pocock, JM and Taylor, DL and Diemel, LT and Cuzner, ML (2003) Expression and function of microglial metabotropic glutamate receptors; Implications for microglial reactivity and neurotoxicity. In: GLIA. (pp. 9 - 9). WILEY-LISS

Polman, C and Kappos, L and White, R and Dahlke, F and Beckmann, K and Pozzilli, C and Thompson, A and Petkau, J and Miller, D and European Study Grp Interferon, (2003) Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b. NEUROLOGY , 60 (1) 37 - 43.

Pryce, G and Ahmed, Z and Hankey, DJR and Jackson, SJ and Croxford, JL and Pocock, JM and Ledent, C and Petzold, A and Thompson, AJ and Giovannoni, G and Cuzner, ML and Baker, D (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. BRAIN , 126 2191 - 2202. 10.1093/brain/awg224.

Pryce, G. and Ahmed, Z. and Hankey, D.J.R. and Jackson, S.J. and Croxford, J.L. and Pocock, J.M. and Ledent, C. and Petzold, A. and Thompson, A.J. and Giovannoni, G. and Cuzner, M.L. and Baker, D. (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain , 126 (10) pp. 2191-2202. 10.1093/brain/awg224.

R

Rashid, W and Hadjiprocopis, A and Griffin, CM and Chard, DT and Davies, GR and Altmann, DR and Barker, GJ and Thompson, AJ and Miller, DH (2003) Brain tissue diffusion abnormalities may occur early in relapsing-remitting multiple sclerosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1457 - 1457). B M J PUBLISHING GROUP

Rashid, W and Miller, DH (2003) Perfusion MRI. In: Filippi, M and Comi, G, (eds.) NEW FRONTIERS OF MR-BASED TECHNIQUES IN MULTIPLE SCLEROSIS. (pp. 73 - 82). SPRINGER-VERLAG ITALIA

Reiber, H and Thompson, EJ and Grimsley, G and Bernardi, G and Adam, P and de Almeida, SM and Fredman, P and Keir, G and Lammers, M and Liblau, R and Menna-Barreto, MM and Maria, JS and Seres, E and Sindic, CJM and Teelken, A and Trendelenburg, C and Trojano, M and van Antwerpen, MP and Verbeek, MM (2003) Quality assurance for cerebrospinal fluid protein analysis: International consensus by an Internet-based group discussion. Clinical Chemistry and Laboratory Medicine , 41 (3) 331 - 337.

Rejdak, K and Petzold, A and Sharpe, MA and Smith, M and Keir, G and Stelmasiak, Z and Thompson, EJ and Giovannoni, G (2003) Serum and urine nitrate and nitrite are not reliable indicators of intrathecal nitric oxide production in acute brain injury. J NEUROL SCI , 208 (1-2) 1 - 7. 10.1016/S0022-510X(02)00412-4.

Rugg-Gunn, F.J. and Eriksson, S.H. and Boulby, P.A. and Symms, M.R. and Barker, G.J. and Duncan, J.S. (2003) Magnetization transfer imaging in focal epilepsy. Neurology , 60 (10) pp. 1638-1645.

S

Sastre-Garriga, J and Ingle, GT and Ramio, L and Miller, DH and Thompson, AJ (2003) Inflammation in early primary progressive multiple sclerosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1457 - 1457). B M J PUBLISHING GROUP

Schmierer, K and Scaravilli, F and Barker, GJ and Gordon, R and MacManus, DG and Miller, DH (2003) Stereotactic co-registration of magnetic resonance imaging and histopathology in post-mortem multiple sclerosis brain. NEUROPATH APPL NEURO , 29 (6) 596 - 601. 10.1046/j.1365-2990.2003.0497.x.

Sormani, MP and Bruzzi, P and Beckmann, K and Wagner, K and Miller, DH and Kappos, L and Filippi, M and European Study Grp Interferon Beta, (2003) MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-lb. NEUROLOGY , 60 (9) 1462 - 1466.

Southworth, R and Parry, CR and Parkes, HG and Medina, RA and Garlick, PB (2003) Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a F-19 NMR spectroscopy study in the rat. NMR BIOMED , 16 (8) 494 - 502.

T

Taylor, D.L. and Diemel, L.T. and Pocock, J.M. (2003) Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. The Journal of Neuroscience , 23 (6) pp. 2150-2160.
An open access version is available from UCL Discovery
file

Taylor, DL and Diemel, LT and Pocock, JM (2003) Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J NEUROSCI , 23 (6) 2150 - 2160.

Taylor, DL and Jones, F and Pocock, JM (2003) Metabotropic glutamate receptor modulation of TNF-alpha release from microglia. In: (Proceedings) VI European Meeting on glial cell function in health and disease.. (pp. P248 - ?). Glia

Taylor, DL and Jones, F and Pocock, JM (2003) Metabotropic glutamate receptor modulation of TNF-alpha release from microglia. In: GLIA. (pp. 74 - 74). WILEY-LISS

Tijssen, MA and Brown, P and MacManus, D and McLean, MA and Davie, C (2003) Magnetic resonance spectroscopy of cerebral cortex is normal in hereditary hyperekplexia due to mutations in the GLRA1 gene. Mov Disord , 18 (12) 1538 - 1541. 10.1002/mds.10613.

Toosy, AT and Hickman, SJ and Plant, GT and Barker, GJ and Miller, DH and Thompson, AJ (2003) A functional magnetic resonance imaging study of the longitudinal response to photic stimulation following acute optic neuritis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1451 - 1451). B M J PUBLISHING GROUP

Toosy, AT and Werring, DJ and Orrell, RW and Howard, RS and King, MD and Barker, GJ and Miller, DH and Thompson, AJ (2003) Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J NEUROL NEUROSUR PS , 74 (9) 1250 - 1257.

Tozer, D and Ramani, A and Barker, GJ and Davies, GR and Miller, DH and Tofts, PS (2003) Quantitative magnetization transfer mapping of bound protons in multiple sclerosis. MAGN RESON MED , 50 (1) 83 - 91. 10.1002/mrm.10514.

Tozer, DJ and Tofts, PS (2003) Removing spikes caused by quantization noise from high-resolution histograms. MAGN RESON MED , 50 (3) 649 - 653. 10.1002/mrm.10561.

Traboulsee, A and Dehmeshki, J and Peters, KR and Griffin, CM and Brex, PA and Silver, N and Ciccarrelli, O and Chard, DT and Barker, GJ and Thompson, AJ and Miller, D (2003) Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities. MULT SCLER , 9 (6) 566 - 573. 10.1191/1352458503ms958oa.

Trip, SA and Wroe, SJ and Davies, G and Giovannoni, G (2003) Primary CNS mantle cell lymphoma associated with an isolated CSF monoclonal IgG band. EUR NEUROL , 49 (3) 187 - 188. 10.1159/000069080.

W

Wheeler-Kingshott, C (2003) DTI and fMRI - Complementary information. In: Ng, V and Barker, GJ and Hendler, T, (eds.) PSYCHIATRIC NEUROIMAGING. (pp. 48 - 54). I O S PRESS

Wheeler-Kingshott, CA and Barker, GJ and Steens, SCA and van Buchem, MA (2003) D: the diffusion of water. In: Tofts, PS, (ed.) Quantitative MRI of the brain: measuring changes caused by disease. (203 - 256). John Wiley: Chichester.

This list was generated on Wed May 22 08:56:56 2013 BST.